Search Results - Mayenga, Marie

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases

    Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases by Mayenga, Marie, Assié, Jean-Baptiste, Monnet, Isabelle, Massiani, Marie-Ange, Tabeze, Laure, Friard, Sylvie, Fraboulet, Séverine, Métivier, Anne-Cécile, Chouaïd, Christos, Zemoura, Leïla, Longchampt, Elisabeth, Callens, Céline, Melaabi, Samia, Couderc, Louis-Jean, Doubre, Hélène

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer

    Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer by Takam Kamga, Paul, Mayenga, Marie, Sebane, Louise, Costantini, Adrien, Julie, Catherine, Capron, Claude, Parent, Florence, Seferian, Andrei, Guettier, Catherine, Emile, Jean-François, Giroux Leprieur, Etienne

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancer

    The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancer by Mayenga, Marie, Pedroso, Ana Rita, Ferreira, Marion, Gille, Thomas, Pereira Catarata, Maria Joana, Duchemann, Boris

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued

    Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued by Mayenga, Marie, Falvo, Nicolas, Mahé, Isabelle, Jannot, Anne-Sophie, Gazeau, Benoit, Meyer, Guy, Gendron, Nicolas, Sanchez, Olivier, Djennaoui, Sadji, Planquette, Benjamin

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab

    Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab by Talb, Jamila, Takam Kamga, Paul, Mayenga, Marie, Costantini, Adrien, Julié, Catherine, Dumenil, Coraline, Dumoulin, Jennifer, Ouaknine, Julia, Giraud, Violaine, Dujon, Cécile, Azarian, Reza, Glaser, Claire, Emile, Jean-François, Giroux Leprieur, Etienne

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Lorlatinib – Induced pulmonary arterial hypertension

    Lorlatinib – Induced pulmonary arterial hypertension by Chabrol, Alexandre, Mayenga, Marie, Hamid, Abdul Momen, Friard, Sylvie, Salvator, Hélène, Doubre, Hélèe, Fraboulet, Séverine, Metivier, Anne-Cécile, Catherinot, Emilie, Rivaud, Elisabeth, Chaumais, Marie Camille, Montani, David, Couderc, Louis Jean, Tcherakian, Colas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: